vs

Side-by-side financial comparison of Playboy, Inc. (PLBY) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.

SOLENO THERAPEUTICS INC is the larger business by last-quarter revenue ($66.0M vs $34.9M, roughly 1.9× Playboy, Inc.). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs 10.3%, a 29.1% gap on every dollar of revenue. SOLENO THERAPEUTICS INC produced more free cash flow last quarter ($43.5M vs $1.1M).

Playboy is an American men's lifestyle and entertainment magazine, available both online and in print. It was founded in Chicago in 1953 by Hugh Hefner and his associates, funded in part by a $1,000 loan from Hefner's mother.

SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.

PLBY vs SLNO — Head-to-Head

Bigger by revenue
SLNO
SLNO
1.9× larger
SLNO
$66.0M
$34.9M
PLBY
Higher net margin
SLNO
SLNO
29.1% more per $
SLNO
39.4%
10.3%
PLBY
More free cash flow
SLNO
SLNO
$42.3M more FCF
SLNO
$43.5M
$1.1M
PLBY

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
PLBY
PLBY
SLNO
SLNO
Revenue
$34.9M
$66.0M
Net Profit
$3.6M
$26.0M
Gross Margin
73.3%
98.3%
Operating Margin
7.9%
33.5%
Net Margin
10.3%
39.4%
Revenue YoY
4.2%
Net Profit YoY
128.6%
134.0%
EPS (diluted)
$0.05
$0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PLBY
PLBY
SLNO
SLNO
Q4 25
$34.9M
Q3 25
$29.0M
$66.0M
Q2 25
$28.1M
$32.7M
Q1 25
$28.9M
Q4 24
$33.5M
Q3 24
$29.4M
Q2 24
$24.9M
Q1 24
$28.3M
Net Profit
PLBY
PLBY
SLNO
SLNO
Q4 25
$3.6M
Q3 25
$460.0K
$26.0M
Q2 25
$-7.7M
$-4.7M
Q1 25
$-9.0M
Q4 24
$-12.5M
Q3 24
$-33.8M
Q2 24
$-16.7M
Q1 24
$-16.4M
Gross Margin
PLBY
PLBY
SLNO
SLNO
Q4 25
73.3%
Q3 25
76.0%
98.3%
Q2 25
65.4%
97.9%
Q1 25
68.6%
Q4 24
70.8%
Q3 24
61.0%
Q2 24
67.8%
Q1 24
55.8%
Operating Margin
PLBY
PLBY
SLNO
SLNO
Q4 25
7.9%
Q3 25
4.7%
33.5%
Q2 25
-20.9%
-20.0%
Q1 25
-21.7%
Q4 24
-13.3%
Q3 24
-96.0%
Q2 24
-37.0%
Q1 24
-31.5%
Net Margin
PLBY
PLBY
SLNO
SLNO
Q4 25
10.3%
Q3 25
1.6%
39.4%
Q2 25
-27.3%
-14.4%
Q1 25
-31.3%
Q4 24
-37.4%
Q3 24
-114.7%
Q2 24
-66.9%
Q1 24
-58.1%
EPS (diluted)
PLBY
PLBY
SLNO
SLNO
Q4 25
$0.05
Q3 25
$0.00
$0.47
Q2 25
$-0.08
$-0.09
Q1 25
$-0.10
Q4 24
$-0.13
Q3 24
$-0.45
Q2 24
$-0.23
Q1 24
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PLBY
PLBY
SLNO
SLNO
Cash + ST InvestmentsLiquidity on hand
$37.8M
$498.9M
Total DebtLower is stronger
$174.2M
Stockholders' EquityBook value
$18.4M
$494.8M
Total Assets
$292.4M
$599.9M
Debt / EquityLower = less leverage
9.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PLBY
PLBY
SLNO
SLNO
Q4 25
$37.8M
Q3 25
$27.5M
$498.9M
Q2 25
$19.6M
$286.8M
Q1 25
$23.7M
Q4 24
$30.9M
Q3 24
$9.5M
Q2 24
$16.9M
Q1 24
$19.0M
Total Debt
PLBY
PLBY
SLNO
SLNO
Q4 25
$174.2M
Q3 25
$176.8M
Q2 25
$177.5M
Q1 25
$176.3M
Q4 24
$176.6M
Q3 24
$200.0M
Q2 24
$196.3M
Q1 24
$193.4M
Stockholders' Equity
PLBY
PLBY
SLNO
SLNO
Q4 25
$18.4M
Q3 25
$3.8M
$494.8M
Q2 25
$-17.5M
$240.1M
Q1 25
$-11.4M
Q4 24
$-7.7M
Q3 24
$-15.7M
Q2 24
$15.7M
Q1 24
$29.5M
Total Assets
PLBY
PLBY
SLNO
SLNO
Q4 25
$292.4M
Q3 25
$278.3M
$599.9M
Q2 25
$264.1M
$332.3M
Q1 25
$270.6M
Q4 24
$284.7M
Q3 24
$271.5M
Q2 24
$301.8M
Q1 24
$309.1M
Debt / Equity
PLBY
PLBY
SLNO
SLNO
Q4 25
9.48×
Q3 25
46.86×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
12.51×
Q1 24
6.54×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PLBY
PLBY
SLNO
SLNO
Operating Cash FlowLast quarter
$1.4M
$43.5M
Free Cash FlowOCF − Capex
$1.1M
$43.5M
FCF MarginFCF / Revenue
3.2%
65.8%
Capex IntensityCapex / Revenue
0.8%
0.0%
Cash ConversionOCF / Net Profit
0.39×
1.67×
TTM Free Cash FlowTrailing 4 quarters
$-1.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PLBY
PLBY
SLNO
SLNO
Q4 25
$1.4M
Q3 25
$10.1M
$43.5M
Q2 25
$-3.9M
$-12.6M
Q1 25
$-7.6M
Q4 24
$161.0K
Q3 24
$-6.5M
Q2 24
$-3.0M
Q1 24
$-9.8M
Free Cash Flow
PLBY
PLBY
SLNO
SLNO
Q4 25
$1.1M
Q3 25
$9.8M
$43.5M
Q2 25
$-4.3M
$-12.6M
Q1 25
$-7.7M
Q4 24
$-401.0K
Q3 24
$-7.0M
Q2 24
$-3.7M
Q1 24
$-10.3M
FCF Margin
PLBY
PLBY
SLNO
SLNO
Q4 25
3.2%
Q3 25
33.8%
65.8%
Q2 25
-15.2%
-38.6%
Q1 25
-26.5%
Q4 24
-1.2%
Q3 24
-23.7%
Q2 24
-14.8%
Q1 24
-36.5%
Capex Intensity
PLBY
PLBY
SLNO
SLNO
Q4 25
0.8%
Q3 25
1.1%
0.0%
Q2 25
1.4%
0.0%
Q1 25
0.1%
Q4 24
1.7%
Q3 24
1.5%
Q2 24
2.6%
Q1 24
2.1%
Cash Conversion
PLBY
PLBY
SLNO
SLNO
Q4 25
0.39×
Q3 25
22.02×
1.67×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PLBY
PLBY

Transferred At Point In Time$22.2M64%
Trademark Licensing$6.5M19%
Related Party$5.0M14%
Other$1.1M3%

SLNO
SLNO

Segment breakdown not available.

Related Comparisons